Ben Bronstein - 08 Jun 2021 Form 4 Insider Report for Aldeyra Therapeutics, Inc. (ALDX)

Role
Director
Signature
/s/ Ben Bronstein
Issuer symbol
ALDX
Transactions as of
08 Jun 2021
Transactions value $
$0
Form type
4
Filing time
10 Jun 2021, 17:44:58 UTC
Next filing
09 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALDX Stock Option (Right to Buy) Award $0 +13.5K $0.00 13.5K 08 Jun 2021 Common Stock 13.5K $12.97 Direct F1
transaction ALDX Stock Option (Right to Buy) Award $0 +875 $0.00 875 08 Jun 2021 Common Stock 875 $12.97 Direct F2
transaction ALDX Stock Option (Right to Buy) Award $0 +933 $0.00 933 08 Jun 2021 Common Stock 933 $12.97 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.
F2 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date.
F3 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date.